iShares Trust - iShares Biotechnology ETF
NASDAQIBB, the iShares Biotechnology ETF, heads into the back half of September with short interest near a multi-month high and options traders the most defensive they have been in weeks — a combination that captures just how divided biotech sentiment has become. Short interest has been building quietly but persistently. At 21.96% of free float, IBB carries one of the more significant…
Snapshot as of 16 Sept 2026
IBB, the iShares Biotechnology ETF, heads into the back half of September with short interest near a multi-month high and options traders the most defensive they have been in weeks — a combination that captures just…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IBB — free to start on ORTEX.
Sign up for free →Open IBB on ORTEX